Key Points Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified lineup of products than its peer. Even considering its seemingly more reasonable valuation, Novo Nordisk comes in second place. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have a lot in common. They both have made significant breakthroughs in the market for diabetes medicine, a field in which they have been competing with one another for de ...